Literature DB >> 33351166

Summary of the Detection Kits for SARS-CoV-2 Approved by the National Medical Products Administration of China and Their Application for Diagnosis of COVID-19.

Ruhan A1, Huijuan Wang1, Wenling Wang2, Wenjie Tan3.   

Abstract

The on-going global pandemic of coronavirus disease 2019 (COVID-19) caused by a novel coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been underway for about 11 months. Through November 20, 2020, 51 detection kits for SARS-CoV-2 nucleic acids (24 kits), antibodies (25 kits), or antigens (2 kits) have been approved by the National Medical Products Administration of China (NMPA). Convenient and reliable SARS-CoV-2 detection assays are urgently needed worldwide for strategic control of the pandemic. In this review, the detection kits approved in China are summarised and the three types of tests, namely nucleic acid, serological and antigen detection, which are available for the detection of COVID-19 are discussed in detail. The development of novel detection kits will lay the foundation for the control and prevention of the COVID-19 pandemic globally.

Entities:  

Keywords:  Chemiluminescence immunoassay (CLIA); Detection kits; Lateral flow immunoassay (LFIA); Real-time RT-PCR; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Year:  2020        PMID： 33351166     DOI： 10.1007/s12250-020-00331-1

Source DB:  PubMed          Journal:  Virol Sin        ISSN： 1995-820X            Impact factor:   4.327


  31 in total

Review 1.  COVID-19: Current Trends in Invitro Diagnostics.

Authors:  R Arun Krishnan; Rhema Elizabeth Thomas; Ajaikumar Sukumaran; Jofy K Paul; D M Vasudevan
Journal:  Indian J Clin Biochem       Date:  2020-06-27

2.  SARS-CoV-2 lgM/lgG antibody detection confirms the infection after three negative nucleic acid detection.

Authors:  Hua Li; Jue Pan; Yi Su; Beili Wang; Junbo Ge
Journal:  J Cell Mol Med       Date:  2020-05-19       Impact factor: 5.310

Review 3.  Active case finding with case management: the key to tackling the COVID-19 pandemic.

Authors:  Zhongjie Li; Qiulan Chen; Luzhao Feng; Lance Rodewald; Yinyin Xia; Hailiang Yu; Ruochen Zhang; Zhijie An; Wenwu Yin; Wei Chen; Ying Qin; Zhibin Peng; Ting Zhang; Daxin Ni; Jinzhao Cui; Qing Wang; Xiaokun Yang; Muli Zhang; Xiang Ren; Dan Wu; Xiaojin Sun; Yuanqiu Li; Lei Zhou; Xiaopeng Qi; Tie Song; George F Gao; Zijian Feng
Journal:  Lancet       Date:  2020-06-04       Impact factor: 79.321

4.  Assay Techniques and Test Development for COVID-19 Diagnosis.

Authors:  Linda J Carter; Linda V Garner; Jeffrey W Smoot; Yingzhu Li; Qiongqiong Zhou; Catherine J Saveson; Janet M Sasso; Anne C Gregg; Divya J Soares; Tiffany R Beskid; Susan R Jervey; Cynthia Liu
Journal:  ACS Cent Sci       Date:  2020-04-30       Impact factor: 14.553

5.  Dynamic profile for the detection of anti-SARS-CoV-2 antibodies using four immunochromatographic assays.

Authors:  Baptiste Demey; Nagib Daher; Catherine François; Jean-Philippe Lanoix; Gilles Duverlie; Sandrine Castelain; Etienne Brochot
Journal:  J Infect       Date:  2020-05-07       Impact factor: 6.072

Review 6.  Lateral flow assays.

Authors:  Katarzyna M Koczula; Andrea Gallotta
Journal:  Essays Biochem       Date:  2016-06-30       Impact factor: 8.000

7.  Clinical application of Chemiluminescence Microparticle Immunoassay for SARS-CoV-2 infection diagnosis.

Authors:  Wanbing Liu; Guomei Kou; Yaoyu Dong; Yaqiong Zheng; Yinjuan Ding; Wenxu Ni; Wanlei Wu; Shi Tang; Zhou Xiong; Ying Zhang; Lei Liu; Shangen Zheng
Journal:  J Clin Virol       Date:  2020-08-01       Impact factor: 3.168

8.  Evidence informing the UK's COVID-19 public health response must be transparent.

Authors:  Nisreen A Alwan; Raj Bhopal; Rochelle A Burgess; Tim Colburn; Luis E Cuevas; George Davey Smith; Matthias Egger; Sandra Eldridge; Valentina Gallo; Mark S Gilthorpe; Trish Greenhalgh; Christopher Griffiths; Paul R Hunter; Shabbar Jaffar; Ruth Jepson; Nicola Low; Adrian Martineau; David McCoy; Miriam Orcutt; Bharat Pankhania; Hynek Pikhart; Allyson Pollock; Gabriel Scally; James Smith; Devi Sridhar; Stephanie Taylor; Peter W G Tennant; Yrene Themistocleous; Anne Wilson
Journal:  Lancet       Date:  2020-03-17       Impact factor: 79.321

9.  Serological chemiluminescence immunoassay for the diagnosis of SARS-CoV-2 infection.

Authors:  Shao Lijia; Shen Lihong; Wang Huabin; Xu Xiaoping; Lu Xiaodong; Zhu Yixuan; He Pin; Xu Yina; Shan Xiaoyun; Wu Junqi
Journal:  J Clin Lab Anal       Date:  2020-07-16       Impact factor: 2.352

Review 10.  Recent progress on the diagnosis of 2019 Novel Coronavirus.

Authors:  Chun Li; Linzhu Ren
Journal:  Transbound Emerg Dis       Date:  2020-05-31       Impact factor: 4.521
View more
  6 in total

1.  Preparation of the luciferase-labeled antibody for improving the detection sensitivity of viral antigen.

Authors:  Ying Tang; Yuchang Li; Sen Zhang; Jing Li; Yi Hu; Wenguang Yang; Yuehong Chen; Chengfeng Qin; Tao Jiang; Xiaoping Kang
Journal:  Virol J       Date:  2022-07-28       Impact factor: 5.913

Review 2.  SARS-CoV-2 Molecular Diagnostics in China.

Authors:  Yanjun Lu; Ziyong Sun
Journal:  Clin Lab Med       Date:  2022-03-04       Impact factor: 2.172

3.  Microfluidic particle dam for direct visualization of SARS-CoV-2 antibody levels in COVID-19 vaccinees.

Authors:  Minghui Wu; Siying Wu; Gaobo Wang; Wengang Liu; Lok Ting Chu; Tianyi Jiang; Hoi Kwan Kwong; Hiu Lam Chow; Iris Wai Sum Li; Ting-Hsuan Chen
Journal:  Sci Adv       Date:  2022-06-03       Impact factor: 14.957

4.  High-specificity targets in SARS-CoV-2 N protein for serological detection and distinction from SARS-CoV.

Authors:  Jianhai Yu; Zhiran Qin; Xuling Liu; Xiaoen He; Jinxiu Yao; Xuan Zhou; Kun Wen; Nan Yu; Qinghua Wu; Weiwei Xiao; Li Zhu; Chengsong Wan; Bao Zhang; Wei Zhao
Journal:  Comput Biol Med       Date:  2022-01-29       Impact factor: 4.589

Review 5.  Monoplex and multiplex immunoassays: approval, advancements, and alternatives.

Authors:  Haseeb Ahsan
Journal:  Comp Clin Path       Date:  2021-11-20

6.  Accuracy of novel antigen rapid diagnostics for SARS-CoV-2: A living systematic review and meta-analysis.

Authors:  Lukas E Brümmer; Stephan Katzenschlager; Mary Gaeddert; Christian Erdmann; Stephani Schmitz; Marc Bota; Maurizio Grilli; Jan Larmann; Markus A Weigand; Nira R Pollock; Aurélien Macé; Sergio Carmona; Stefano Ongarello; Jilian A Sacks; Claudia M Denkinger
Journal:  PLoS Med       Date:  2021-08-12       Impact factor: 11.069
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.